LUKE EVNIN

Profile

First Name

: LUKE

Middle Name

:

Last Name

: EVNIN

Related Companies
Titles
Company Name
Related People
DIRECTOR
ENTEROMEDICS INC
NAQEEB A ANSARI, GARY BLACKFORD, GARY D BLACKFORD, PETER M DELANGE, ADRIANUS JOS DONDERS, CATHERINE FRIEDMAN, DAN GLADNEY, DAN W GLADNEY, CARL GOLDFISCHER, BOBBY I GRIFFIN, BOBBY IVAN GRIFFIN, DONALD C HARRISON, PAUL F HICKEY, PAUL KLINGENSTEIN, MARK B KNUDSON, ELLEN KOSKINAS, GREG S LEA, LORI MCDOUGAL, LORI C MCDOUGAL, RAJESH NIHALANI, NICHOLAS L TETI, NICHOLAS L TETI, JR., JON TREMMEL, JON T TREMMEL, SCOTT YOUNGSTROM, SCOTT P YOUNGSTROM
PROMOTER
MPM BIOVENTURES V, L.P.
ASHLEY DOMBKOWSKI, ANSBERT GADICKE, WILLIAM GREENE, VAUGHN M. KAILIAN, N/A MPM BIOVENTURES V GP LLC, N/A MPM BIOVENTURES V LLC, JAMES S. SCOPA, STEVEN ST. PETER, JOHN W. VANDER VORT
DIRECTOR
COSTIM PHARMACEUTICALS INC.
JEAN-FRANCOIS FORMELA, ROGER KITTERMAN, ROBERT MILLMAN, MARIAN NAKADA, JOSH RESNICK, KAZUMI SHIOSAKI
DIRECTOR
AMPHIVENA THERAPEUTICS, INC.
VINAY BHASKAR, FLORIAN FISCHER, JEANMARIE GUENOT, PHIL GUTRY, ADI HOESS, MARK MCDADE, ERIC MOESSINGER, FRANK MUHLENBECK, CHRISTIAN RICHARD, PETER VAN VASSELAER
DIRECTOR
POTENZA THERAPEUTICS, INC.
SAKAE ASANUMA, DAVID CORDO, PHIL GUTRY, DANIEL HICKLIN, REID LEONARD, SHUNICHIRO MATSUMOTO, ARNOLD ORONSKY, CYNTHIA SEIDEL-DUGAN, JAMES WESCOTT
DIRECTOR
VESUVIUS PHARMACEUTICALS, INC.
DAVID CORDO, PHIL GUTRY, DANIEL HICKLIN, ARNOLD ORONSKY
DIRECTOR
ONCORUS, INC.
THEODORE ASHBURN, THOMAS CHALBERG, MARY KAY FENTON, MITCHELL FINER, ROBERT KIRKMAN, ALON LAZARUS, JOHN MCCABE, BRIGGS MORRISON, CYRUS MOZAYENI, SPENCER NAM, CHRISTOPHE QUEVA, MARC RECHT, CAMERON WHEELER
DIRECTOR
BLADE THERAPEUTICS, INC.
RANA AL-HALLAQ, M. SHIRLEY CHIANG, PRABHA IBRAHIM, ELAINE JONES, LLOYD B. KLICKSTEIN, GARY PATOU, WENDYE ROBBINS, WENDYE RAE ROBBINS, JAMES SCOPA, WILLIAM SLATTERY, WILLIAM V. SLATTERY, PETER VAN VLASSELAER, CAMERON WHEELER
DIRECTOR
DIGITX PARTNERS LLC
DAVID J. KIM, NAOKI OKAMURA
DIRECTOR
TRIEZA THERAPEUTICS, INC.
DAVID CORDO, DANIEL HICKLIN
DIRECTOR
MAVERICK THERAPEUTICS INC.
CHRISTOPHER ARENDT, BARD GEESAMAN, HANS PETER GERBER, DAN HICKLIN, LORI KUNKEL
DIRECTOR
HARPOON THERAPEUTICS, INC.
PATRICK BAEUERLE, JOSEPH BAILES, PABLO CAGNONI, MARK CHIN, ALAN COLOWICK, JONATHAN DRACHMAN, JULIE EASTLAND, GEORGIA L. ERBEZ, DAN HICKLIN, RON HUNT, RONALD HUNT, GERALD MCMAHON, SCOTT MYERS, WILLIAM E. PICHT, ANDREW ROBBINS, NATALIE R. SACKS, LAUREN SILVERNAIL, LAUREN P. SILVERNAIL, JOANNE VINEY, LUKE WALKER, LUKE NATHANIEL WALKER, HOLGER WESCHE
DIRECTOR
TWENTYEIGHT-SEVEN, INC.
CHRISTINE BRENNAN, BRIGGS MORRISON, MARIAN NAKADA, CAROLYN NG, HENRIJETTE RICHTER, KAZUMI SHIOSAKI, MICHAL SILVERBERG
EXECUTIVE OFFICER, PROMOTER
MPM ONCOLOGY INNOVATIONS FUND LP
ANSBERT GADICKE, N/A MPM ONCOLOGY INNOVATIONS FUND GP LLC
DIRECTOR
FRONTIER MEDICINES CORP
GREGORY CHOW, JOHANNES HERMANN, PH.D., OTHMAN LARAKI, JANWILLEM NAESENS, CHRIS VARMA, PH.D., KEVIN WEBSTER, CAMERON WHEELER, JIM WINKLER
DIRECTOR
WEREWOLF THERAPEUTICS, INC.
SAKAE ASANUMA, PATRICK BAEUERLE, DAVID CORDO, DEREK DIROCCO, DANIEL HICKLIN, ALON LAZARUS, BRIGGS MORRISON, ELISE WANG, CHRISTOPH WESTPHAL
DIRECTOR
UMOJA BIOPHARMA, INC.
ANNA FRENCH, ROBERT GLASSMAN, JOHN HAMER, PHILIP S. LOW, IRENA MELNIKOVA, ANDREW M. SCHARENBERG
DIRECTOR
REDONA THERAPEUTICS, INC.
CHRISTINE BRENNAN, BRIGGS MORRISON, MARIAN NAKADA, CAROLYN NG, HENRIJETTE RICHTER, KAZUMI SHIOSAKI, MICHAL SILVERBERG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-07-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-07-21 
2023-07-31
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-22 
2022-06-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-22 
2021-07-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-25 
2021-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-06-09 
2021-01-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-23 
2020-11-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-18 
2020-08-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-02 
2020-02-26
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2018-07-12 
2019-12-20
D/A
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-08-05 
2019-10-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-08 
2019-10-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-23 
2019-08-20
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-05 
2019-08-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-02 
2019-07-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-18 
2019-07-01
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2018-07-12 
2018-12-19
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-10 
2018-11-26
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2018-09-21
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2018-09-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-22 
2017-12-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-19 
2017-07-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-17 
2017-06-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-11 
2017-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-24 
2017-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-06 
2016-12-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-21 
2016-12-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-22 
2016-11-14
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2016-08-05
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2016-08-04
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-26 
2016-06-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-08 
2016-04-14
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2016-03-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-12-02 
2015-05-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-11 
2015-01-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-22 
2014-12-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-12-02 
2013-07-26
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-07-11 
2013-04-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-29 
2010-02-12
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-20 
2010-02-12
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-20 
2009-02-27
D
Link
OTHER HEALTH CARE 
ELECTROMEDICAL + ELECTROTHERAPEUTIC APPARATUS [3845] 
DECLINE TO DISCLOSE 
Equity 
2009-02-19